Home > About ActoGeniX > Scientific Advisory Board
ActoGeniX appoints new Chief Executive Officer
ActoGeniX completes Phase 2A clinical trial of AG011
ActoGeniX receives IWT grant for treatment of oral mucositis and starts clinical trial with AG013
Dag van de Biotechnologie